NDC 50594-875 Astringent

Salicylic Acid

NDC Product Information

Astringent with NDC 50594-875 is a a human over the counter drug product labeled by Big Lots. The generic name of Astringent is salicylic acid. The product's dosage form is liquid and is administered via topical form.

Labeler Name: Big Lots

Dosage Form: Liquid - A dosage form consisting of a pure chemical in its liquid1 state. This dosage form term should not be applied to solutions.

Product Type: Human Otc Drug What kind of product is this?
Indicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.

Astringent Active Ingredient(s)

What is the Active Ingredient(s) List?
This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted.

  • SALICYLIC ACID 5 mg/mL

Inactive Ingredient(s)

About the Inactive Ingredient(s)
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product.

  • ALCOHOL (UNII: 3K9958V90M)
  • PHYMATOLITHON CALCAREUM (UNII: 6J1M3WA0ZK)
  • ALOE VERA LEAF (UNII: ZY81Z83H0X)
  • SULISOBENZONE (UNII: 1W6L629B4K)
  • DENATONIUM BENZOATE (UNII: 4YK5Z54AT2)
  • DIMETHICONE (UNII: 92RU3N3Y1O)
  • GLYCERIN (UNII: PDC6A3C0OX)
  • ISOCETETH-20 (UNII: O020065R7Z)
  • PEG-32 DIOLEATE (UNII: TOM07RFH74)
  • PROPYLENE GLYCOL (UNII: 6DC9Q167V3)
  • SODIUM CITRATE (UNII: 1Q73Q2JULR)
  • WATER (UNII: 059QF0KO0R)
  • FD&C BLUE NO. 1 (UNII: H3R47K3TBD)

Administration Route(s)

What are the Administration Route(s)?
The translation of the route code submitted by the firm, indicating route of administration.

  • Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.

Product Labeler Information

What is the Labeler Name?
Name of Company corresponding to the labeler code segment of the Product NDC.

Labeler Name: Big Lots
Labeler Code: 50594
FDA Application Number: part333D What is the FDA Application Number?
This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.

Marketing Category: OTC MONOGRAPH FINAL - A product marketed pursuant to a final Over-the-Counter (OTC) Drug Monograph. What is the Marketing Category?
Product types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

Start Marketing Date: 03-15-2016 What is the Start Marketing Date?
This is the date that the labeler indicates was the start of its marketing of the drug product.

Listing Expiration Date: 12-31-2021 What is the Listing Expiration Date?
This is the date when the listing record will expire if not updated or certified by the product labeler.

Exclude Flag: N What is the NDC Exclude Flag?
This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA’s requests for correction to deficient or non-compliant submissions. Values = ‘Y’ or ‘N’.

* Please review the disclaimer below.

Information for Patients

Salicylic Acid Topical

Salicylic Acid Topical is pronounced as (sal'' i sil' ik as' id)

Why is salicylic acid topical medication prescribed?
Topical salicylic acid is used to help clear and prevent pimples and skin blemishes in people who have acne. Topical salicylic acid is also used to treat skin conditions ...
[Read More]

* Please review the disclaimer below.

Astringent Product Label Images

Astringent Product Labeling Information

The product labeling information includes all published material associated to a drug. Product labeling documents include information like generic names, active ingredients, ingredient strength dosage, routes of administration, appearance, usage, warnings, inactive ingredients, etc.

Product Labeling Index

Active Ingredinet

Salicylic acid 0.5%

Purpose

Acne medication

Use

For the treatment of acne

Warnings

For external use onlyFlammable. Keep away from fire or flame

When Using This Product

  • Skin irritation and dryness is more likely to occur if you use another topical acne medication at the same time.  If irrition occurs, only use one topical acne medication at a time

Keep Out Of Reach Of Children.

If swallowed, get medical help or contact a Poison Control Center right away.

Directions

  • Clean the skin thoroughly before applying this productcover the entire affected are with a thin layer and rinse thoroughly one to three times dailybecause excessive drying of the sking may occur, start with one application daily, then grdually increase to two or three times daily if needed or as directed by a doctorif bothersome dryness or peeling occurs, reduce daily application to once a day or every other day

Inactvie Ingredients

Alcohol (24.5%), algae extract, aloe barbadensis leaf extract, benzophenone-4, denatonium benzoate, dimethicone propyl PG-getaine, fragance, glycerin, isoceteth-20, PEG-32, propylene glycol, sodium citrate, water, blue 1

Other

*This product is not manufactured or distributed by Johnson & Johnson Consumer Products Company, distributor of Clean & Clear Sensitive Skin Deep Cleaning Astringent.Manufactured for Big Lots by: Vi-Jon, Inc.8515 Page Avenue; St. Louis, MO 63114Made in the USA with US and Foreign Components

* Please review the disclaimer below.